EcoDrugPlus

Kinesin Family Member 5b

Ensembl ID : ENSUAMG00000011679
Gene Symbol: KIF5B
2 Cross references
281 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSUAMG00000008013
Gene Symbol: LTA4H
2 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSUAMG00000024413
Gene Symbol: LTB4R
2 Cross references
140 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSUAMG00000024412
Gene Symbol: LTB4R2
2 Cross references
236 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSUAMG00000022536
Gene Symbol: KDM1A
2 Cross references
213 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSUAMG00000007349
Gene Symbol: LOXL2
2 Cross references
287 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSUAMG00000010804
Gene Symbol: MIF
2 Cross references
218 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSUAMG00000007186
Gene Symbol: MST1R
2 Cross references
119 Possible Orthologues:

Maltase-Glucoamylase

Ensembl ID : ENSUAMG00000025773
Gene Symbol: MGAM
2 Cross references
312 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSUAMG00000017421
Gene Symbol: MMP1
2 Cross references
352 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSUAMG00000007482
Gene Symbol: MMP12
2 Cross references
550 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSUAMG00000007483
Gene Symbol: MMP13
2 Cross references
200 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).